Bristol Population Health Science Institute

Largest trial of antibiotic amoxicillin for treating chest infections in children finds little effect

The largest randomised placebo-controlled trial of the antibiotic amoxicillin for treating chest infections in children - one of the most common acute illnesses treated in primary care in developed countries, has found it is little more effective at relieving symptoms than the use of no medication. The study, published in The Lancet and funded by the National Institute for Health Research (NIHR), was led by researchers from the University of Southampton and supported by centres at the Universities of Bristol, Oxford and Cardiff.

Long COVID in children poorly understood by doctors

The clinical definition of long COVID in children is at present very limited and poorly understood by doctors, according to a new report published today [21 July]. The report also found that symptoms typically associated with long COVID were having a significant physical and psychological impact on children’s day-to-day lives. Long COVID is commonly used to describe signs and symptoms that continue or develop after acute COVID‑19.